{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:30:12Z","timestamp":1780561812693,"version":"3.54.1"},"publisher-location":"Cham","reference-count":103,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031631177","type":"print"},{"value":"9783031631184","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/82_2022_253","type":"book-chapter","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T14:03:13Z","timestamp":1655301793000},"page":"1-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Brief History of Human Challenge Studies (1900\u20132021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D\u2019etre, Ethnography, Selection of Volunteers and Unit Design"],"prefix":"10.1007","author":[{"given":"J. S.","family":"Oxford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Catchpole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Noulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Oxford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobana","family":"Balasingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"253_CR1","unstructured":"Akst J (08\/10\/2020) A challenge trial for COVID-19 would not be the first of its kind|The scientist magazine\u00ae retrieved from a challenge trial for COVID-19 would not be the first of its kind|The scientist magazine\u00ae (the-scientist.com) (accessed 23 May 2021)"},{"issue":"5","key":"253_CR2","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1067\/mai.2000.106214","volume":"105","author":"PC Avila","year":"2000","unstructured":"Avila PC, Abisheganaden JA, Wong H, Liu J, Yagi S, Schnurr D, Kishiyama JL, Boushey HA (2000) Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol 105(5):923\u2013932","journal-title":"J Allergy Clin Immunol"},{"key":"253_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2016.05.013","volume":"49","author":"S Balasingam","year":"2016","unstructured":"Balasingam S, Wilder-Smith A (2016) Randomised controlled trials for influenza drugs and vaccines: a review of controlled human infections studies. Int J Infect Dis 49:18\u201329","journal-title":"Int J Infect Dis"},{"issue":"9","key":"253_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.11622\/smedj.2014114","volume":"55","author":"S Balasingam","year":"2014","unstructured":"Balasingam S, Horby P, Wilder-Smith A (2014) The potential for a controlled human infection platform in Singapore. Singapore Med J 55(9):456\u2013461","journal-title":"Singapore Med J"},{"key":"253_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1183\/09031936.00.16598000","volume":"16","author":"PG Bardin","year":"2000","unstructured":"Bardin PG, Fraenkel DJ, Sanderson G, van Schalkwyk EM, Holgate ST, Johnston SL (2000) Peak expiratory flow changes during experimental rhinovirus infection. Eur Respir J 16:980\u2013985","journal-title":"Eur Respir J"},{"key":"253_CR6","doi-asserted-by":"crossref","unstructured":"Baay M, Neels P (2020) SARS\u2010CoV\u20102 controlled human infection models: ethics, challenge agent production and regulatory issues. Biologicals Sep 67:69\u201374","DOI":"10.1016\/j.biologicals.2020.08.006"},{"key":"253_CR7","doi-asserted-by":"crossref","unstructured":"Beare AS, Read S (1977) The study of antiviral compounds in volunteers. In: Oxford JS (ed) chemoprophylaxis and viral infections of the respiratory tract, vol 2. CRC, Cleveland, p 27","DOI":"10.1201\/9781351070621-2"},{"key":"253_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jinf.2004.07.011","volume":"50","author":"JB Beckham","year":"2005","unstructured":"Beckham JB, Cadena A, Lin J et al (2005) Respiratory viral infections in patients with chronic obstructive pulmonary disease. J Infect 50:322\u2013330","journal-title":"J Infect"},{"key":"253_CR9","doi-asserted-by":"publisher","unstructured":"Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinj\u00e9 J, Gregoricus N, Frenck RW Jr, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM. (2015) Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis 211(6):870\u2013878. https:\/\/doi.org\/10.1093\/infdis\/jiu497. Epub 2014 Sep 9. PMID: 25210140; PMCID: PMC5914500","DOI":"10.1093\/infdis\/jiu497"},{"issue":"7831","key":"253_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/d41586-020-02821-4","volume":"586","author":"E Callaway","year":"2020","unstructured":"Callaway E (2020) Dozens to be deliberately infected with coronavirus in UK \u2018human challenge\u2019 trials. Nature 586(7831):651\u2013652","journal-title":"Nature"},{"issue":"7","key":"253_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.it.2009.05.002","volume":"30","author":"WH Chen","year":"2009","unstructured":"Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB (2009) Vaccination in the elderly: an immunological perspective. Trends Immunol 30(7):351\u2013359","journal-title":"Trends Immunol"},{"key":"253_CR12","doi-asserted-by":"publisher","unstructured":"Chen WH, Cohen MB, Kirkpatrick BD, Brady RC, Galloway D, Gurwith M, Hall RH, Kessler RA, Lock M, Haney D, Lyon CE, Pasetti MF, Simon JK, Szabo F, Tennant S, Levine MM (2016) Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with vibrio cholerae O1 El Tor. Clin Infect Dis 62(11):1329\u20131335. https:\/\/doi.org\/10.1093\/cid\/ciw145. Epub 2016 Mar 21. PMID: 27001804; PMCID: PMC4872293","DOI":"10.1093\/cid\/ciw145"},{"key":"253_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4269\/ajtmh.1986.35.66","volume":"35","author":"JD Chulay","year":"1986","unstructured":"Chulay JD, Schneider I, Cosgriff TM, Hoffman SL, Ballou WR, Quakyi IA, Carter R, Trosper JH, Hockmeyer WT (1986) Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg 35:66\u201368","journal-title":"Am J Trop Med Hyg"},{"key":"253_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jvec.12261","volume":"42","author":"AN Clements","year":"2017","unstructured":"Clements AN, Harbach RE (2017) History of the discovery of the mode of transmission of yellow fever virus. J Vector Ecol 42:208\u2013222","journal-title":"J Vector Ecol"},{"key":"253_CR15","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 18 Apr 2019) Identifier NCT03919591, RSV Study in Adults 60\u201375 Years of Age [cited 02 July 2021] available at RSV Study in Adults 60\u201375 Years of Age\u2014Full Text View\u2014ClinicalTrials.gov"},{"key":"253_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7205\/MILMED-D-15-00430","volume":"181","author":"L Cutter","year":"2016","unstructured":"Cutter L (2016) Walter reed, yellow fever, and informed consent. Mil Med 181:90\u201391","journal-title":"Mil Med"},{"issue":"8","key":"253_CR17","doi-asserted-by":"publisher","first-page":"e0004926","DOI":"10.1371\/journal.pntd.0004926","volume":"10","author":"TC Darton","year":"2016","unstructured":"Darton TC, Jones C, Blohmke CJ, Waddington CS, Zhou L, Peters A, Haworth K, Sie R, Green CA, Jeppesen CA, Moore M, Thompson BA, John T, Kingsley RA, Yu LM, Voysey M, Hindle Z, Lockhart S, Sztein MB, Dougan G, Angus B, Levine MM, Pollard AJ (2016) Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with Placebo and Ty21a. PLoS Negl Trop Dis 10(8):e0004926. https:\/\/doi.org\/10.1371\/journal.pntd.0004926 PMID: 27533046; PMCID: PMC4988630","journal-title":"PLoS Negl Trop Dis"},{"key":"253_CR18","unstructured":"Defoe D (1722) A journal of the plague year 1665, London"},{"issue":"2","key":"253_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jaci.2009.05.030","volume":"124","author":"JP DeMore","year":"2009","unstructured":"DeMore JP, Weisshaar EH, Vrtis RF, Swenson CA, Evans MD, Morin A, Hazel E, Bork JA, Kakumanu S, Sorkness R, Busse WW, Gern JE (2009) Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol 124(2):245\u2013252","journal-title":"J Allergy Clin Immunol"},{"key":"253_CR20","doi-asserted-by":"publisher","unstructured":"Diemert D, Campbell D, Brelsford J, Leasure C, Li G, Peng J, Zumer M, Younes N, Bottazzi ME, Mejia R, Pritchard DI, Hawdon JM, Bethony JM (2018) Controlled human hookworm infection: accelerating human hookworm vaccine development. Open Forum Infect Dis. 5(5):ofy083. https:\/\/doi.org\/10.1093\/ofid\/ofy083. PMID: 29780848; PMCID: PMC5952933","DOI":"10.1093\/ofid\/ofy083"},{"issue":"7","key":"253_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2009.04.006","volume":"30","author":"MR Dowling","year":"2009","unstructured":"Dowling MR, Hodgkin PD (2009) Why does the thymus involute? A selection-based hypothesis. Trends Immunol 30(7):295\u2013300","journal-title":"Trends Immunol"},{"key":"253_CR22","doi-asserted-by":"publisher","unstructured":"Doyle WJ, Skoner DP, Alper CM, Allen G, Moody SA, Seroky JT, Hayden FG (1998) Effect of Rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. J Infect Dis 177(5):1260\u20131265. https:\/\/doi.org\/10.1086\/515294","DOI":"10.1086\/515294"},{"key":"253_CR23","unstructured":"Dujarric de la Rivi\u00e8re (1918) La grippe est-elle une maladie \u00e0 virus filtrant? Comptes rendus hebdomadaires des s\u00e9ances de l\u2019Acad\u00e9mie des Sciences, 606\u2013607"},{"issue":"5","key":"253_CR24","first-page":"312","volume":"XXXVIII","author":"NM Fairley","year":"1945","unstructured":"Fairley NM (1945) Chemotherapeutic suppression and prophylaxis in Malaria; An experimental investigation undertaken by medical research teams in Australia. Trans R Soc Trop Med Hyg XXXVIII(5):312\u2013354","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"253_CR25","first-page":"414","volume":"1894","author":"C Finlay","year":"1894","unstructured":"Finlay C (1894) Yellow fever. Edinb Med J 1894:414\u2013421","journal-title":"Edinb Med J"},{"issue":"1","key":"253_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1164\/ajrccm.160.1.9808074","volume":"160","author":"HE Fleming","year":"1999","unstructured":"Fleming HE, Little FF, Schnurr D, Avila PC, Wong H, Liu J, Yagi S, Boushey HA (1999) Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 160(1):100\u2013108","journal-title":"Am J Respir Crit Care Med"},{"key":"253_CR27","unstructured":"Food and Drug Administration (2016) FDA approves vaccine to prevent cholera for travellers, 10 June 2016 [Accessed 2 July 2021]. Available at www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm506305.htm"},{"key":"253_CR28","doi-asserted-by":"publisher","unstructured":"Ghebre MA, Bell A, Mann A (2019) A key endpoint in viral challenge models of asthma exacerbations. Eur Respir J 54(suppl 63):PA347. https:\/\/doi.org\/10.1183\/13993003.congress-2019.PA347","DOI":"10.1183\/13993003.congress-2019.PA347"},{"key":"253_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.12688\/wellcomeopenres.12256.1","volume":"2","author":"SB Gordon","year":"2017","unstructured":"Gordon SB, Rylance J, Luck A et al (2017) A framework for controlled human infection model (CHIM) studies in Malawi: Report of a Wellcome trust workshop on CHIM in low income countries held in Blantyre, Malawi [version 1; peer review: 2 approved]. Wellcome Open Res 2:70","journal-title":"Wellcome Open Res"},{"key":"253_CR30","doi-asserted-by":"publisher","unstructured":"Han A, Czajkowski LM, Donaldson A, Baus HA, Reed SM, Athota RS, Bristol T, Rosas LA, Cervantes-Medina A, Taubenberger JK, Memoli MJ (2019) A dose-finding study of a wild-type influenza A (H3N2) virus in a healthy volunteer human challenge model. Clin Infect Dis Official Publ Infect Dis Soc Am 69(12):2082\u20132090. https:\/\/doi.org\/10.1093\/cid\/ciz141","DOI":"10.1093\/cid\/ciz141"},{"issue":"13","key":"253_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","volume":"282","author":"FG Hayden","year":"1999","unstructured":"Hayden FG, Treanor JJ, Fritz RS et al (1999) Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282(13):1240\u20131246. https:\/\/doi.org\/10.1001\/jama.282.13.1240","journal-title":"JAMA"},{"issue":"5","key":"253_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0178096","volume":"12","author":"PW Heymann","year":"2017","unstructured":"Heymann PW, Nguyen HT, Steinke JW, Turner RB, Woodfolk JA, Platts-Mills TAE, Martin L, He H, Myers JB, Lindsey M, Sivaprasas U, Medvedovic M, Mahi N, Carper H, Murphy DD, Patrie J, Khurana Hershey GK (2017) Rhinovirus infection results in stronger and more persistent genomic dysregulation: evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescence. PLoS ONE 12(5):1\u201317","journal-title":"PLoS ONE"},{"issue":"12","key":"253_CR33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","volume":"190","author":"DJ Jackson","year":"2014","unstructured":"Jackson DJ et al (2014) IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190(12):1373\u20131382","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"253_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jaci.2015.01.028","volume":"136","author":"DJ Jackson","year":"2015","unstructured":"Jackson DJ et al (2015) The influence of asthma control on the severity of virus-induced asthma exacerbations. J Allergy Clin Immunol 136(2):497\u2013500","journal-title":"J Allergy Clin Immunol"},{"key":"253_CR35","doi-asserted-by":"publisher","unstructured":"Jamrozik E, Selgelid MJ (2021) Ethical issues. In: Human challenge studies in endemic settings. SpringerBriefs in ethics. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-41480-1_3","DOI":"10.1007\/978-3-030-41480-1_3"},{"issue":"4","key":"253_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.vaccine.2020.10.075","volume":"39","author":"E Jamrozik","year":"2020","unstructured":"Jamrozik E, Littler K, Bull S, Emerson C, Kang G, Kapulu M, Rey E, Saenz C, Shah S, Smith PG et al (2020) Key criteria for the ethical acceptability of COVID-19 human challenge studies: report of a WHO working group. Vaccine 39(4):633\u2013640","journal-title":"Vaccine"},{"issue":"5","key":"253_CR37","first-page":"543","volume":"17","author":"S Janson-Bjerklie","year":"1988","unstructured":"Janson-Bjerklie S, Shnell S (1988) Effect of peak flow information on patterns of self-care in adult asthma. Heart Lung 17(5):543\u2013549","journal-title":"Heart Lung"},{"key":"253_CR38","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","volume":"390","author":"C Jin","year":"2017","unstructured":"Jin C, Gibani MM, Moore M et al (2017) Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella typhi: a randomised controlled, phase 2b trial. Lancet 390:2472\u20132480","journal-title":"Lancet"},{"issue":"6989","key":"253_CR39","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","volume":"310","author":"SL Johnston","year":"1995","unstructured":"Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O\u2019Toole S, Myint SH, Tyrrell DA (1995) Community study of role of viral infections in exacerbations of asthma in 9\u201311 year old children. BMJ 310(6989):1225\u20131229","journal-title":"BMJ"},{"key":"253_CR40","doi-asserted-by":"publisher","unstructured":"Kaminski RW, Pasetti MF, Aguilar AO, Clarkson KA, Rijpkema S, Bourgeois AL, Cohen D, Feavers I, MacLennan CA (2019) Consensus report on Shigella controlled human infection model: immunological assays. Clin Infect Dis 69(Suppl 8):S596\u2013S601. https:\/\/doi.org\/10.1093\/cid\/ciz909. PMID: 31816067; PMCID: PMC6901123","DOI":"10.1093\/cid\/ciz909"},{"issue":"7","key":"253_CR42","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1016\/S2214-109X(21)00258-8","volume":"9","author":"P Kamthunzi","year":"2021","unstructured":"Kamthunzi P (2021) Impact of PCV13 vaccination in Blantyre, Malawi. Lancet Glob Health 9(7):e893\u2013e894. https:\/\/doi.org\/10.1016\/S2214-109X(21)00258-8 PMID: 34143985","journal-title":"Lancet Glob Health"},{"key":"253_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.12688\/wellcomeopenres.15337.1","volume":"4","author":"E Kestelyn","year":"2019","unstructured":"Kestelyn E, Le Phuong C, Ilo Van Nuil J et al (2019) Expert voices and equal partnerships: establishing controlled human infection models (CHIMs) in Vietnam [version 1; peer review: 3 approved]. Wellcome Open Res. 4:143","journal-title":"Wellcome Open Res."},{"key":"253_CR45","doi-asserted-by":"crossref","unstructured":"Kirby T (2020) COVID-19 human challenge studies in the UK. Lancet Respir Med Dec 8(12):e96","DOI":"10.1016\/S2213-2600(20)30518-X"},{"issue":"50","key":"253_CR46","doi-asserted-by":"publisher","first-page":"7075","DOI":"10.1016\/j.vaccine.2015.09.052","volume":"33","author":"CP Larsen","year":"2015","unstructured":"Larsen CP, Whitehead SS, Durbin AP (2015) Dengue human infection models to advance dengue vaccine development. Vaccine 33(50):7075\u20137082","journal-title":"Vaccine"},{"key":"253_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0022-2836(64)80094-2","volume":"9","author":"WJ Laver","year":"1964","unstructured":"Laver WJ (1964) Structural studies on the protein subunits from three strains of influenza virus. J Mol Biol 9:109\u2013124","journal-title":"J Mol Biol"},{"issue":"11","key":"253_CR48","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/cid\/ciaa1290","volume":"72","author":"MM Levine","year":"2021","unstructured":"Levine MM, Abdullah S, Arabi YM, Darko DM, Durbin AP, Estrada V et al (2021) Viewpoint of a WHO advisory group tasked to consider establishing a closely-monitored challenge model of COVID-19 in healthy volunteers. Clin Infect Dis 72(11):2035\u20132041","journal-title":"Clin Infect Dis"},{"key":"253_CR49","doi-asserted-by":"publisher","unstructured":"Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B. (2014 Feb) Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 15(2):195\u2013204. https:\/\/doi.org\/10.1038\/ni.2789. Epub 15 Dec 2013. PMID: 24336226; PMCID: PMC3946932","DOI":"10.1038\/ni.2789"},{"key":"253_CR50","doi-asserted-by":"publisher","unstructured":"Li S, Sullivan NL, Rouphael N, Yu T, Banton S, Maddur MS, McCausland M, Chiu C, Canniff J, Dubey S, Liu K, Tran V, Hagan T, Duraisingham S, Wieland A, Mehta AK, Whitaker JA, Subramaniam S, Jones DP, Sette A, Vora K, Weinberg A, Mulligan MJ, Nakaya HI, Levin M, Ahmed R, Pulendran B (2017) Metabolic phenotypes of response to vaccination in humans. Cell 169(5):862\u2013877.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.04.026. Epub 11 May 2017. PMID: 28502771; PMCID: PMC5711477","DOI":"10.1016\/j.cell.2017.04.026"},{"issue":"4","key":"253_CR51","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(19)30584-5","volume":"20","author":"D Liebowitz","year":"2020","unstructured":"Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, Kim K, McIlwain DR, Tucker SN (2020) Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. Lancet Infect Dis 20(4):435\u2013444. https:\/\/doi.org\/10.1016\/S1473-3099(19)30584-5 Epub 2020 Jan 21 PMID: 31978354","journal-title":"Lancet Infect Dis"},{"key":"253_CR52","unstructured":"LSTM (2021) Delivering integrated solutions for human infections. Delivering integrated solutions for human infections|LSTM (lstmed.ac.uk) (accessed 13 Oct 2021)"},{"key":"253_CR53","doi-asserted-by":"crossref","unstructured":"MacLennan CA, Riddle MS, Chen WH, Talaat KR, Jain V, Bourgeois AL, Frenck R, Kotloff K, Porter CK (2019) Consensus report on Shigella controlled human infection model: clinical endpoints. Clin Infect Dis 69(Suppl 8):S591\u2013S595","DOI":"10.1093\/cid\/ciz891"},{"key":"253_CR54","unstructured":"Maddipatla M (2020) Dutch researchers preparing for \u2018human challenge\u2019 COVID-19 vaccine trial|Reuters (accessed 23 May 2021)"},{"key":"253_CR55","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1465-9921-7-116","volume":"7","author":"P Mallia","year":"2006","unstructured":"Mallia P, Message SD, Kebadze T et al (2006) An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res 7:116","journal-title":"Respir Res"},{"issue":"6","key":"253_CR56","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1164\/rccm.201006-0833OC","volume":"183","author":"P Mallia","year":"2011","unstructured":"Mallia P, Message SD, Gielen V et al (2011) Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183(6):734\u2013742","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"253_CR57","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1164\/rccm.201205-0806OC","volume":"186","author":"P Mallia","year":"2012","unstructured":"Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo M-B, Kebadze T, Aniscenko J, Oleszkiewicz G, Gray K, Message SD, Ito K, Barnes PJ, Adcock IM, Papi A, Stanciu LA, Elkin SL, Kon OM, Johnson M, Johnston SL (2012) Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(11):734\u2013742","journal-title":"Am J Respir Crit Care Med"},{"key":"253_CR58","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.vaccine.2013.12.040","volume":"32","author":"MP Mammen","year":"2014","unstructured":"Mammen MP, Lyons A, Innis BL, Sun W, McKinney D, Chung RC, Eckels KH, Putnak R, Kanesathasan N, Scherer JM, Statler J, Asher LV, Thomas SJ, Vaughn DW (2014) Evaluation of dengue virus strains for human challenge studies. Vaccine 32:1488\u20131494","journal-title":"Vaccine"},{"key":"253_CR59","doi-asserted-by":"crossref","unstructured":"Mann A, Ghenbre MA, Bell AS (2019) Temporal relationships of cytokines, chemokines and cellular biomarkers during human rhinovirus (HRV) infection in asthmatics. Eur Respir J. Accessed 16 June 2021. Available at: https:\/\/erj.ersjournals.com\/content\/54\/suppl_63\/OA3564","DOI":"10.1183\/13993003.congress-2019.OA3564"},{"key":"253_CR60","doi-asserted-by":"crossref","unstructured":"Manson P (1879) On the development of Filaria saguinis hominis, and on the mosquito considered as a nurse. In: Proceedings of the Linnean Society of London, Zoology","DOI":"10.1111\/j.1096-3642.1878.tb01837.x"},{"issue":"8","key":"253_CR62","doi-asserted-by":"publisher","first-page":"e21914","DOI":"10.1371\/journal.pone.0021914","volume":"6","author":"JS McCarthy","year":"2011","unstructured":"McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, Rockett R, O\u2019Rourke P, Marquart L, Hermsen C, Duparc S, M\u00f6hrle J, Trenholme KR, Humberstone AJ (2011) A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS ONE 6(8):e21914. https:\/\/doi.org\/10.1371\/journal.pone.0021914","journal-title":"PLoS ONE"},{"key":"253_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM198307073090103","volume":"309","author":"AJ McMichael","year":"1983","unstructured":"McMichael AJ, Gotch FM, Noble GR, Beare PA (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309:13\u201317","journal-title":"N Engl J Med"},{"issue":"9","key":"253_CR64","doi-asserted-by":"publisher","first-page":"e24092","DOI":"10.1371\/journal.pone.0024092","volume":"6","author":"HJ McSorley","year":"2011","unstructured":"McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, Ruyssers NE, Speare R, McCarthy JS, Engwerda CR, Croese J, Loukas A (2011) Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS ONE 6(9):e24092. https:\/\/doi.org\/10.1371\/journal.pone.0024092","journal-title":"PLoS ONE"},{"key":"253_CR65","doi-asserted-by":"crossref","unstructured":"Memoli MJ et al (2015) Validation of the wild type influenza A human challenge model. Clin Infect Dis 60(5):693\u2013702","DOI":"10.1093\/cid\/ciu924"},{"issue":"36","key":"253_CR66","doi-asserted-by":"publisher","first-page":"13562","DOI":"10.1073\/pnas.0804181105","volume":"105","author":"SD Message","year":"2008","unstructured":"Message SD et al (2008) Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1\/2 cytokine and IL-10 production. PNAS 105(36):13562\u201313567","journal-title":"PNAS"},{"key":"253_CR67","unstructured":"MHRA Guidance on strain changes in authorised COVID-19 vaccines. Retrieved from Guidance on strain changes in authorised COVID-19 vaccines\u2014GOV.UK (www.gov.uk) (accessed 27 May 2021)"},{"key":"253_CR68","doi-asserted-by":"publisher","unstructured":"Morton B, Burr S, Chikaonda T, Nsomba E, Manda-Taylor L, Henrion MYR, Banda NP, Rylance J, Ferreira DM, Jambo K, Gordon SB, MARVELS consortium (2021) A feasibility study of controlled human infection with Streptococcus pneumoniae in Malawi. EBioMedicine 72:103579. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103579. Epub ahead of print. PMID: 34571365","DOI":"10.1016\/j.ebiom.2021.103579"},{"key":"253_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.12688\/wellcomeopenres.16587.1","volume":"6","author":"N Mtunthama Toto","year":"2021","unstructured":"Mtunthama Toto N, Gooding K, Kapumba BM et al (2021) \u201cAt first, I was very afraid\u201d\u2014a qualitative description of participants\u2019 views and experiences in the first Human Infection Study in Malawi [version 1; peer review: 1 approved, 1 approved with reservations]. Wellcome Open Res 6:89","journal-title":"Wellcome Open Res"},{"key":"253_CR70","doi-asserted-by":"publisher","unstructured":"Murphy BR, Chanock RM, Levine MM, van Blerk GA, Berquist EJ, Douglas RG, Betts RF, Couch RB, Cate TR Jr (1979) Temperature-sensitive mutants of influenza A virus: evaluation of the A\/Victoria\/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Infect Immun 23(2):249\u2013252. https:\/\/doi.org\/10.1128\/iai.23.2.249-252.1979. PMID: 422239; PMCID: PMC414156","DOI":"10.1128\/iai.23.2.249-252.1979"},{"key":"253_CR71","unstructured":"Nicolle CJH, Lebailly C (1918) Quelques notions exp\u00e9rimentales sur le virus de la grippe. Comptes rendus hebdomadaires des s\u00e9ances de l\u2019Acad\u00e9mie des Sciences 607\u2013610"},{"key":"253_CR72","doi-asserted-by":"publisher","unstructured":"Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, Thompson-Snipes L, Ranganathan R, Zeitner B, Bjork A, Anderson D, Speake C, Ruchaud E, Skinner J, Alsina L, Sharma M, Dutartre H, Cepika A, Israelsson E, Nguyen P, Nguyen QA, Harrod AC, Zurawski SM, Pascual V, Ueno H, Nepom GT, Quinn C, Blankenship D, Palucka K, Banchereau J, Chaussabel D (2013) Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 18;38(4):831\u2013844. https:\/\/doi.org\/10.1016\/j.immuni.2012.12.008. PMID: 23601689; PMCID: PMC3681204","DOI":"10.1016\/j.immuni.2012.12.008"},{"issue":"8","key":"253_CR73","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1586\/14760584.7.8.1239","volume":"7","author":"MR Olson","year":"2008","unstructured":"Olson MR, Varga SM (2008) Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. Expert Rev Vaccines 7(8):1239\u20131255","journal-title":"Expert Rev Vaccines"},{"key":"253_CR74","doi-asserted-by":"publisher","unstructured":"Osowicki J, Azzopardi KI, McIntyre L, Rivera-Hernandez T, Ong C-LY, Baker C, Gillen CM, Walker MJ, Smeesters PR, Davies MR, Steer AC (2019) A controlled human infection model of group A Streptococcus pharyngitis: which strain and why? mSphere 4:e00647\u201318. https:\/\/doi.org\/10.1128\/mSphere.00647-18","DOI":"10.1128\/mSphere.00647-18"},{"key":"253_CR75","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0042-6822(76)90345-7","volume":"74","author":"JS Oxford","year":"1976","unstructured":"Oxford JS, Schild GC (1976) Immunological and physicochemical studies of influenza matrix (M1) polypeptides. Virology 74:394\u2013402","journal-title":"Virology"},{"key":"253_CR76","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/273778a0","volume":"273","author":"JS Oxford","year":"1978","unstructured":"Oxford JS, McGeoch DJ, Schild GC, Beare AS (1978) Analysis of virion RNA segments and polypeptides of influenza A virus recombinant of defined virulence. Nature 273:778\u2013779","journal-title":"Nature"},{"key":"253_CR77","doi-asserted-by":"crossref","unstructured":"Oxford JS, Schild GC, Beare AS et al (1990) A host cell selected variant of influenza B with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated for virulence in volunteers. Arch Virol 110:37\u201346","DOI":"10.1007\/BF01310701"},{"key":"253_CR78","doi-asserted-by":"crossref","unstructured":"Oxford JS, Gilbert A, Lambkin-Williams R (2011) Influenza vaccines have a short but illustrious history of dedicated science enabling the rapid global production of A\/Swine (H1N1) vaccine in the current pandemic. In: Rappuoli R, Del Giudice G (eds) Influenza vaccines for the future. Springer Basel, pp 115\u2013147","DOI":"10.1007\/978-3-0346-0279-2_6"},{"key":"253_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/erv.12.77","volume":"11","author":"JS Oxford","year":"2012","unstructured":"Oxford JS, Oxford JR (2012) Clinical scientific and ethnographic studies of influenza in quarantine. Expert Rev Vaccines 11:1\u20139","journal-title":"Expert Rev Vaccines"},{"key":"253_CR80","doi-asserted-by":"publisher","unstructured":"Pi\u00f1eros YS, Bal SM, van de Pol MA, Dierdorp BS, Dekker T, Dijkhuis A, Brinkman P, van der Sluijs KF, Zwinderman AH, Majoor CJ, Bonta PI, Ravanetti L, Sterk PJ, Lutter R. (2019) Anti-IL-5 in mild asthma alters rhinovirus-induced macrophage, B-cell, and neutrophil responses (MATERIAL). A placebo-controlled, double-blind study. Am J Respir Crit Care Med 199(4):508\u2013517. https:\/\/doi.org\/10.1164\/rccm.201803-0461OC. PMID: 30192638","DOI":"10.1164\/rccm.201803-0461OC"},{"key":"253_CR81","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1473-3099(12)70292-X","volume":"12","author":"AJ Pollard","year":"2012","unstructured":"Pollard AJ, Savulescu J, Oxford J et al (2012) Human microbial challenge: the ultimate animal model. Lancet Infect Dis 12:903\u2013905","journal-title":"Lancet Infect Dis"},{"key":"253_CR82","unstructured":"R&D Blueprint Team (2020) Feasibility, potential value and limitations of establishing a closely monitored challenge model of experimental COVID-19 infection and illness in healthy young adult volunteers. Available: www.who.int\/publications\/m\/item\/feasibility-potential-value-and-limitations-of-establishing-a-closely-monitored-challenge-model-of-experimental-covid19-infection-and-illness-in-healthy-young-adult-volunteers"},{"key":"253_CR83","doi-asserted-by":"publisher","unstructured":"Rapeport G, Smith E, Gilbert A, Catchpole A, McShane H, Chiu C. (2021) SARS-CoV-2 human challenge studies\u2014establishing the model during an evolving pandemic. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMp2106970. Epub ahead of print. PMID: 34289273","DOI":"10.1056\/NEJMp2106970"},{"key":"253_CR84","unstructured":"Rosenau MJ et al (1921) Series of experiments at Boston, February and March, 1919. US Public Health Service, Hygienic Laboratory. Bulletin No. 123, pp 54\u201398"},{"issue":"10","key":"253_CR85","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1016\/S1473-3099(18)30177-4","volume":"18","author":"M Roestenberg","year":"2018","unstructured":"Roestenberg M, Hoogerwerf MA, Ferreira DM, Mordm\u00fcller B, Yazdanbakhsh M (2018) Experimental infection of human volunteers. Lancet Infect Dis 18(10):e312\u2013e322","journal-title":"Lancet Infect Dis"},{"key":"253_CR86","doi-asserted-by":"publisher","unstructured":"Sadoff J, De Paepe E, DeVincenzo J, Gymnopoulou E, Menten J, Murray B, Bastian AR, Vandebosch A, Haazen W, Noulin N, Comeaux C, Heijnen E, Eze K, Gilbert A, Lambkin-Williams R, Schuitemaker H, Callendret B. (2021) Prevention of respiratory syncytial virus infection in healthy adults by a single immunization of Ad26.RSV.preF in a human challenge study. J Infect Dis 5:jiab003. https:\/\/doi.org\/10.1093\/infdis\/jiab003. Epub ahead of print. PMID: 33400792","DOI":"10.1093\/infdis\/jiab003"},{"key":"253_CR87","doi-asserted-by":"publisher","first-page":"578801","DOI":"10.3389\/fimmu.2020.578801","volume":"11","author":"CP Shannon","year":"2020","unstructured":"Shannon CP, Blimkie TM, Ben-Othman R, Gladish N, Amenyogbe N, Drissler S, Edgar RD, Chan Q, Krajden M, Foster LJ, Kobor MS, Mohn WW, Brinkman RR, Le Cao KA, Scheuermann RH, Tebbutt SJ, Hancock REW, Koff WC, Kollmann TR, Sadarangani M, Lee AH (2020) Multi-omic data integration allows baseline immune signatures to predict Hepatitis B vaccine response in a small cohort. Front Immunol 11:578801. https:\/\/doi.org\/10.3389\/fimmu.2020.578801 PMID: 33329547; PMCID: PMC7734088","journal-title":"Front Immunol"},{"issue":"9","key":"253_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcimb.2019.00107","volume":"17","author":"AC Sherman","year":"2019","unstructured":"Sherman AC, Mehta A, Dickert NW, Anderson EJ, Rouphael N (2019) The future of flu: a review of the human challenge model and systems biology for advancement of influenza vaccinology. Front Cell Infect Microbiol 17(9):107","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"253_CR89","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jaci.2017.06.027","volume":"141","author":"PE Silkoff","year":"2018","unstructured":"Silkoff PE, Flavin S, Gordon R, Loza MJ, Sterk PJ, Lutter R, Diamant Z, Turner RB, Lipworth BJ, Proud D, Singh D, Eich A, Backer V, Gern JE, Herzmann C, Halperin SA, Mensinga TT, Del Vecchio AM, Branigan P, San Mateo L, Baribaud F, Barnathan ES, Johnston SL (2018) Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: a randomized controlled study. J Allergy Clin Immunol 141(4):1220\u20131230. https:\/\/doi.org\/10.1016\/j.jaci.2017.06.027 Epub 2017 Jul 20 PMID: 28734844","journal-title":"J Allergy Clin Immunol"},{"key":"253_CR91","doi-asserted-by":"crossref","unstructured":"Sloan SE, Szretter KJ, Sundaresh B, Narayan KM, Smith PF, Skurnik D, Bedard S, Trevejo JM, Oldach D, Shriver Z (2020) Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study. Antiviral Res 184:104763","DOI":"10.1016\/j.antiviral.2020.104763"},{"key":"253_CR92","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00000441-193708000-00002","volume":"194","author":"AA Smorodintsev","year":"1937","unstructured":"Smorodintsev AA, Tushinsky MD, Drobyshevskaya AI, Korovin AA, Osetroff AI (1937) Investigation of volunteers infected with the influenza virus. Am J Med Sci 194:159\u2013170","journal-title":"Am J Med Sci"},{"issue":"4","key":"253_CR93","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jaci.2008.07.041","volume":"122","author":"RL Sorkness","year":"2008","unstructured":"Sorkness RL et al (2008) The asthma index: a continuous variable to characterize exacerbations of asthma. J Allergy Clin Immunol 122(4):838\u2013840","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"253_CR94","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1093\/infdis\/jiu063","volume":"209","author":"M Spring","year":"2014","unstructured":"Spring M, Polhemus M, Ockenhouse C (2014) Controlled human malaria infection. J Infect Dis 209(Suppl 2):S40\u2013S45. https:\/\/doi.org\/10.1093\/infdis\/jiu063 PMID: 24872394","journal-title":"J Infect Dis"},{"issue":"5","key":"253_CR95","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/infdis\/jis744","volume":"207","author":"W Sun","year":"2013","unstructured":"Sun W, Eckels KH, Putnak JR, Lyons AG, Thomas SJ, Vaughn DW, Gibbons RV, Fernandez S, Gunther VJ, Mammen MP Jr, Statler JD, Innis BL (2013) Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines. J Infect Dis 207(5):700\u2013708. https:\/\/doi.org\/10.1093\/infdis\/jis744 Epub 2012 Dec 5 PMID: 23225894","journal-title":"J Infect Dis"},{"key":"253_CR96","doi-asserted-by":"publisher","first-page":"103310","DOI":"10.1016\/j.ebiom.2021.103310","volume":"66","author":"KR Talaat","year":"2021","unstructured":"Talaat KR, Alaimo C, Martin P, Bourgeois AL, Dreyer AM, Kaminski RW, Porter CK, Chakraborty S, Clarkson KA, Brubaker J, Elwood D, Fr\u00f6lich R, DeNearing B, Weerts H, Feijoo BL, Halpern J, Sack D, Riddle MS, Fonck VG (2021) Human challenge study with a Shigella bioconjugate vaccine: analyses of clinical efficacy and correlate of protection. EBioMedicine 66:103310. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103310","journal-title":"EBioMedicine"},{"key":"253_CR97","doi-asserted-by":"crossref","unstructured":"Talaat KR, Bourgeois AL. Frenck RW, Chen WH, MacLennan CA, Riddle MS, Suvarnapunya AE, Brubaker JL, Kotloff KL, Porter CK. (2019) Consensus report on Shigella controlled human infection model: conduct of studies. Clin Infect Dis 69 (Suppl 8):S580\u2013S590","DOI":"10.1093\/cid\/ciz892"},{"issue":"2","key":"253_CR98","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1128\/iai.36.2.645-650.1982","volume":"36","author":"MD Tolpin","year":"1982","unstructured":"Tolpin MD, Clements ML, Levine MM, Black RE, Saah AJ, Anthony WC, Cisneros L, Chanock RM, Murphy BR (1982) Evaluation of a phenotypic revertant of the A\/Alaska\/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses. Infect Immun 36(2):645\u2013650. https:\/\/doi.org\/10.1128\/iai.36.2.645-650.1982 PMID: 7085075; PMCID: PMC351277","journal-title":"Infect Immun"},{"key":"253_CR99","doi-asserted-by":"crossref","unstructured":"Tyrrell D, Fielder M (2002) Cold wars: the fight against the common cold","DOI":"10.1093\/oso\/9780192632852.001.0001"},{"key":"253_CR100","unstructured":"The SAGE Working Group on Typhoid Vaccines, WHO Secretariat (2017) Background paper to SAGE on typhoid vaccine policy recommendations. World Health Organization, Geneva, 2017"},{"key":"253_CR101","unstructured":"University of Antwerp (2020) News\u2014Centre of evaluation of vaccination. University of Antwerp (uantwerpen.be) (accessed 13 Oct 2021)"},{"key":"253_CR102","doi-asserted-by":"publisher","DOI":"10.1007\/s40592-020-00121-1","author":"M Vaz","year":"2020","unstructured":"Vaz M, Timms O, Johnson AR et al (2020) Public perceptions on controlled human infection model (CHIM) studies\u2014a qualitative pilot study from South India. Monash Bioeth Rev. https:\/\/doi.org\/10.1007\/s40592-020-00121-1","journal-title":"Monash Bioeth Rev"},{"issue":"6","key":"253_CR103","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/514136","volume":"176","author":"JB Walker","year":"1997","unstructured":"Walker JB, Hussey WK, Treanor JJ, Montalvo A Jr, Hayden FG (1997) Effects of the neuraminidase inhibitor Zanamivir on Otologic manifestations of experimental human influenza. J Infect Dis 176(6):1417\u20131422. https:\/\/doi.org\/10.1086\/514136","journal-title":"J Infect Dis"},{"issue":"9","key":"253_CR104","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/infdis\/jit038","volume":"207","author":"EE Walsh","year":"2013","unstructured":"Walsh EE, Peterson DR, Kalkanoglu AE, Lee FE, Falsey AR (2013) Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis 207(9):1424\u20131432","journal-title":"J Infect Dis"},{"key":"253_CR105","doi-asserted-by":"publisher","unstructured":"Watson JM, Francis JN, Mesens S, et al (2015) Characterisation of a wild-type influenza (A\/H1N1) virus strain as an experimental challenge agent in humans. Virol J 13. https:\/\/doi.org\/10.1186\/s12985-015-0240-5. PMID: 25645025; PMCID: PMC4322439","DOI":"10.1186\/s12985-015-0240-5"},{"key":"253_CR106","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","volume":"18","author":"TM Wilkinson","year":"2012","unstructured":"Wilkinson TM, Li CKF, Chui CSC, Huang AK, Perkins M, Lieber JC, Lambkin-Williams R (2012) Pre-existing influenza specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18:274\u2013280","journal-title":"Nat Med"},{"key":"253_CR107","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(01)30275-1","volume":"193","author":"T Yamanouchi","year":"1919","unstructured":"Yamanouchi T, Sakakami K, Iwashima S (1919) The infecting agent in influenza: an experimental research. Lancet 193:971","journal-title":"Lancet"}],"container-title":["Current Topics in Microbiology and Immunology","Human Challenge Studies for Vaccine Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2022_253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T12:04:22Z","timestamp":1729944262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2022_253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031631177","9783031631184"],"references-count":103,"URL":"https:\/\/doi.org\/10.1007\/82_2022_253","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"16 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}